BridgeMD
New treatment option for Multiple Chronic Conditions
Official title Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
ClinicalTrials.gov ID: NCT05282654
What this study is testing
- What it's testing
- This study aims to predict and minimize post-discharge adverse events (AEs) during care transitions through early identification and escalation of patient-reported symptoms to inpatient and ambulatory clinicians by way of predictive algorithms and clinically integrated digital health apps. We will (1) develop and prospectively validate a predictive model of post-discharge AEs for patients with multiple chronic conditions (MCC); (2) combine, adapt, extend, and iteratively refine our EHR-integrated digital health infrastructure in a series of design sessions with patient and clinician participants; (3) conduct a RCT to evaluate the impact of ePRO monitoring on post-discharge AEs for MCC patients discharged from the general medicine service across Brigham Health; and (4) use mixed methods to evaluate barriers and facilitators of implementation and use as we develop a plan for sustainability, scale, and dissemination.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult (18 years or older)
- Hospitalized on the general medicine services at Brigham and Women's Hospital or Brigham and Women's Faulkner Hospital for at least 24 hours
- Have a discharge status of home, home with services, or facility
- English-speaking patients or their English-speaking legally designated healthcare proxy or next of kin (i.e., a family caregiver)
- Non-English-speaking patients who have an English-speaking legally designated healthcare proxy or next of kin (i.e., a family caregiver)
You likely can't join if
- Less than 18 years of age
- Less than two chronic conditions
- Hospitalized less than 24 hours
- No identifiable healthcare proxy or next of kin (i.e., a family caregiver)
See the full eligibility criteria
- Adult (18 years or older)
- Hospitalized on the general medicine services at Brigham and Women's Hospital or Brigham and Women's Faulkner Hospital for at least 24 hours
- Have a discharge status of home, home with services, or facility
- English-speaking patients or their English-speaking legally designated healthcare proxy or next of kin (i.e., a family caregiver)
- Non-English-speaking patients who have an English-speaking legally designated healthcare proxy or next of kin (i.e., a family caregiver)
- Two or more chronic conditions: Anxiety, Asthma\ , Arthritis (Osteoarthritis, Rheumatoid), Atrial Fibrillation, Cancer\ , Cerebral vascular accident, Chronic kidney disease\ , Chronic obstructive pulmonary disease...
- Less than 18 years of age
- Less than two chronic conditions
- Hospitalized less than 24 hours
- No identifiable healthcare proxy or next of kin (i.e., a family caregiver)
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.